Exagen Inc’s recently made public that its 10% Owner NMSIC Co-Investment Fund, L.P. unloaded Company’s shares for reported $1.16 million on Mar 25 ’25. In the deal valued at $3.30 per share,350,000 shares were sold. As a result of this transaction, NMSIC Co-Investment Fund, L.P. now holds 1,758,958 shares worth roughly $13.6 million.
Then, NMSIC Co-Investment Fund, L.P. sold 200,000 shares, generating $660,040 in total proceeds. Upon selling the shares at $3.30, the 10% Owner now owns 2,108,958 shares.
Before that, Black Jeffrey G. bought 22,298 shares. Exagen Inc shares valued at $66,448 were divested by the Chief Financial Officer at a price of $2.98 per share. As a result of the transaction, Black Jeffrey G. now holds 274,492 shares, worth roughly $2.12 million.
KeyBanc Capital Markets downgraded its Exagen Inc [XGN] rating to a Sector weight from a an Overweight in a research note published recently. Canaccord Genuity began covering XGN with “Buy” recommendation on April 15, 2021. KeyBanc Capital Markets started covering the stock on November 10, 2020. It rated XGN as “an Overweight”.
Price Performance Review of XGN
On Tuesday, Exagen Inc [NASDAQ:XGN] saw its stock jump 3.90% to $7.73. Over the last five days, the stock has gained 5.03%. Exagen Inc shares have risen nearly 88.54% since the year began. Nevertheless, the stocks have risen 290.40% over the past one year. While a 52-week high of $7.75 was reached on 06/17/25, a 52-week low of $1.71 was recorded on 03/04/25.
Levels Of Support And Resistance For XGN Stock
The 24-hour chart illustrates a support level at 7.28, which if violated will result in even more drops to 6.83. On the upside, there is a resistance level at 8.00. A further resistance level may holdings at 8.28.
The most recent change occurred on October 08, 2020 when BTIG Research began covering the stock and recommended ‘”a Buy”‘ rating along with a $18 price target.
